About
Mr. Brown is the Founder and CEO of CommEx Advisors, a commercial excellence consulting practice focused on life science tools and diagnostics. Mr. Brown has over 30 years of commercial experience as a Senior level executive with full P&L responsibility and proven ability to build world-class commercial teams including sales force design and deployment, talent acquisition and management and marketing strategy. Central to his success is an intense focus on process improvement and overall commercial execution which has resulted in transformational growth in key metrics including market share gain, revenue, gross margins and profit. Mr. Brown has a reputation as a change agent who will create an environment that challenges the status-quo and encourages innovative thinking to achieve peak performance with focus and clarity around a few, key priorities, especially in turn-around and growth situations. His engagements have included startup and early-stage companies in the laboratory automation, genomic and proteomics sectors. He has served as a consultant to the Board of Directors, acting Chief Commercial Officer and Interim CEO.
Services & Approach
CommEx Advisors specializes in transforming your commercial strategies into impactful outcomes. The approach is rooted in expertise and a commitment to your business's success.
Current & Existing Customers
Commercial Insights Blog
Testimonials
“CommEx Advisors helped us achieve transformative growth in market share, revenue, and profitability. Their expertise and guidance were invaluable in building our commercial team and optimizing our sales funnels and analytics.”
John Smith, CEO of Life Sciences Co.
“We were struggling to scale our business and achieve commercial success. CommEx Advisors helped us transform our commercial organization and achieve significant growth in market share and revenue. Their expertise and guidance were instrumental in our success.”
Jane Doe, CEO of Biotech Co.
“CommEx Advisors helped us optimize our sales funnels and analytics, resulting in significant growth in market share and revenue. Their customized programs and guidance were invaluable in achieving success in the highly competitive life sciences industry.”
Mark Johnson, CEO of Genomics Co.